Riber (ALRIB) H2 2025 earnings summary

Executive summary

• Achieved €40.3m in revenues for 2025, a slight decrease of 2% year-over-year, but with improved margins and net income growth of 27% to €5.2m.

• Strengthened financial fundamentals, with robust profitability and a solid balance sheet.

• Launched ROSIE, a new technology for silicon-based integrated photonics, with first commercial deliveries and partnerships.

• Market orientation increasingly toward photonics, datacom, telecom, and quantum technologies.

Financial highlights

• Gross margin rose to 38.6% (+2.5 pts), operating income up 17% to €5.1m, and net income up 27% to €5.2m.

• Shareholders’ equity increased by €3.7m to €27.3m; financial debt reduced by €2.2m to €1.7m.

• Net cash at €7.5m at year-end, down from €8.6m; financial autonomy at 49.3%.

• Dividend proposed at €0.10 per share (+25%), with a 2.9% yield.

Outlook and guidance

• Order book at year-end was €26.9m, up 24% year-over-year, not including a major 2026 order.

• Strong commercial momentum for ROSIE, with a growing order backlog (+22%) and global expressions of interest.

• Industrialization and commercialization of ROSIE 2 planned for 2026–2027, targeting the accelerating BTO chip market.

• Focus on leveraging AI, data centers, and photonics market growth for sustainable expansion.

• Growth outlook subject to export license approvals.